Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes. (Q44016357)
Jump to navigation
Jump to search
scientific article published in May 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes. |
scientific article published in May 2002 |
Statements
Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes (English)
A J Garber
J Larsen
S H Schneider
B A Piper
Glyburide/Metformin Initial Therapy Study Group
1 reference
1 reference
1 reference